FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy
<p>Abstract</p> <p>Background</p> <p>We studied whether maximum standardized uptake values (SUV) from [<sup>18</sup> F] PET/CT predict clinical outcome after concurrent proton/chemotherapy for stage III non-small cell lung cancer (NSCLC).</p> <p>...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://www.ro-journal.com/content/7/1/144 |